References
The Merck Index, 8th Edition 1968.
GLEASON, M.N., GOSSELIN, R.E., HODGE, H.C. and SMITH, R.P., Clinical Toxicology of Commercial Products, 3rd. Edition (1969), Williams and Wilkins Co.
ESPIIN, D.W.in GOODMAN, L.S. and GILMAN, A., The Pharmacological Basis of Therapeutics, 4th Edition, p. 1032 (1970) Macmillan Co.
KAPLAN, W.D., Science 108, 43 (1948).
AUERBACH, C., Science 110, 419 (1949).
HOARD, D.E., Biochim. Biophys. Acta 40, 62 (1960).
HASELKORN, R. and DOTY, P., J.Biol.Chem. 236, 2738 (1961).
SLATER, E.E., ANDERSON, M.D., and ROSENKRANZ, H.S., Cancer Res. 31, 970 (1971).
KELLY, R.B., ATKINSON, M.R., HUBERMAN, J.A., and KORNBERG, A., Nature 224, 495 (1969).
DE LUCIA, P., and CAIRNS, J., Nature 224, 1164 (1969).
GROSS, J., and GROSS, M., Nature 224, 1166 (1969).
TOWN, D.C., SMITH, K.C., and KAPLAN, H.S., Science 172, 851 (1971).
ROSENKRANZ, H.S., CARR, H.S., and ROSE, H.M., J. Bacteriol. 89, 1354 (1965).
ROSENKRANZ, H.S., CARR, H.S., and MORGAN, C., Biochem. Biophys. Res. Comm. 44, 546 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosenkranz, H.S. Formaldehyde as a possible carcinogen. Bull. Environ. Contam. Toxicol. 8, 242–244 (1972). https://doi.org/10.1007/BF01839520
Issue Date:
DOI: https://doi.org/10.1007/BF01839520